ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...

As part of Phase 2, Salina Area United Way is also introducing a centralized child care administration hub. This hub will serve as a one-stop support system for providers—connecting them to resources, ...

The company noted that its Phase 2 community study, known as POSITS, has started with the first participants being dosed in ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

During this phase, the focus is on testing the protocol’s foundational components. While Peer-to-Peer (P2P) lending model is ...